deltatrials
Completed OBSERVATIONAL NCT03413956

An Observational Study to Explore Clinical Characteristics of the Patients With T1 Non-small Cell Lung Cancer

A Multi-centre Real-world Non-interventional Observational Study to Explore Clinical Characteristics of the Chinese Patients With T1 Non-small Cell Lung Cancer Complicated With Lymph Metastases

Sponsor: Jiangsu Cancer Institute & Hospital

Interventions Surgeries
Updated 6 times since 2018 Last updated: May 18, 2018 Started: Dec 1, 2017 Primary completion: Mar 30, 2018 Completion: Mar 30, 2018
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Non Small Cell Lung Cancer, this trial is completed. The trial is conducted by Jiangsu Cancer Institute & Hospital and has accumulated 6 data snapshots since 2017. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

~Feb 2018 – ~Apr 2018 · 59 days · monthly snapshotRecruiting~Apr 2018 – ~Jun 2018 · 2 months · monthly snapshotRecruiting~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 22 months · monthly snapshotCompleted

Change History

6 versions recorded
  1. Sep 2024 — Present [monthly]

    Completed

  2. Jul 2024 — Sep 2024 [monthly]

    Completed

  3. Jan 2021 — Jul 2024 [monthly]

    Completed

  4. Jun 2018 — Jan 2021 [monthly]

    Completed

    Status: RecruitingCompleted

  5. Apr 2018 — Jun 2018 [monthly]

    Recruiting

    Phase: NANone

Show 1 earlier version
  1. Feb 2018 — Apr 2018 [monthly]

    Recruiting NA

    First recorded

Dec 2017

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Jiangsu Cancer Institute & Hospital
Data source: Jiangsu Cancer Institute & Hospital

For direct contact, visit the study record on ClinicalTrials.gov .